VGCIX yields 4.84% · MRK yields 2.76%● Live data
📍 MRK pulled ahead of the other in Year 1
Combined, VGCIX + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of VGCIX + MRK for your $10,000?
This fund seeks to provide a moderate and sustainable level of current income by investing in a diversified portfolio of global credit bonds. The fund is actively managed and invests primarily in investment-grade corporate and non-corporate obligations, excluding government-guaranteed issues. The portfolio invests in U.S. and non-U.S. securities including developed and emerging markets. The majority of non-U.S. exposure will be hedged to the U.S. dollar. This hedging enables investors to pursue a globally-diversified credit premium without adding currency risk. Like other bond funds, the fund is subject to interest rate risk; increases in interest rates may lead the price of the bonds in the portfolio to decrease, reducing the fund’s NAV. The fund is also subject to emerging markets risk—bonds in these countries tend to be more volatile and less liquid than those in developed countries—and other international risks, such as country/regional risk. Long-term, risk-tolerant investors who want to diversify their bond portfolio may wish to consider this fund.
Full VGCIX Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.